RESMED INC — Director's Dealing 2019

Feb 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-02-15

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-15	ResMed Common Stock	M	3307	$43.63	Acquired	41728	Direct
2019-02-15	ResMed Common Stock	S	3307	$99.95	Disposed	38421	Direct
2019-02-15	ResMed Common Stock	S	1006	$99.95	Disposed	154326	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-15	ResMed Common Stock Options	$43.63	M	3307	Disposed	2020-03-01	ResMed Commmon Stock (3307)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Represents date options first became exercisable. Options vest 1/3 per year.